Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | AMGN | BMY | VRTX | GILD |
| Company | Alkermes Plc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 28.13 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 28.18 | 290.21 | 58.38 | 455.43 | 89.94 |
| Low | 27.49 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 27.76 | 289.58 | 58.12 | 450.82 | 89.72 |
| Change | -0.15 | +1.71 | +0.24 | -0.41 | +1.09 |
| % Change | -0.54% | +0.59% | +0.41% | -0.09% | +1.23% |
| Volume | 325,049 | 1,236,998 | 2,949,518 | 615,652 | 1,473,761 |
| 20-Day Average Volume | 1,629,440 | 2,802,392 | 12,166,871 | 1,300,366 | 7,396,135 |
| Previous Close | 27.91 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 27.77 | 307.40 | 55.93 | 479.28 | 90.89 |
| 20-Day Raw Stochastic | 45.36% | 26.50% | 70.01% | 8.16% | 29.21% |
| 20-Day Relative Strength | 49.54% | 36.21% | 60.86% | 41.13% | 53.72% |
| Weighted Alpha | +12.25 | +1.74 | +26.26 | +18.38 | +26.19 |
| Today's Opinion | 64% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 88% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 64% Buy | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.05% since 11/14/24 | -2.16% since 11/14/24 | -0.34% since 11/14/24 | -6.76% since 11/14/24 | -2.48% since 11/14/24 |
| Low | 27.11 on 11/19/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 28.47 on 11/18/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | +0.22% since 10/21/24 | -8.59% since 10/21/24 | +11.86% since 10/21/24 | -5.62% since 10/21/24 | +4.10% since 10/21/24 |
| Low | 25.67 on 10/31/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 30.30 on 11/12/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -1.73% since 08/21/24 | -12.04% since 08/21/24 | +20.36% since 08/21/24 | -7.17% since 08/21/24 | +19.56% since 08/21/24 |
| Low | 25.65 on 09/10/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 30.30 on 11/12/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +14.09% since 05/21/24 | -8.04% since 05/21/24 | +37.92% since 05/21/24 | +2.09% since 05/21/24 | +33.49% since 05/21/24 |
| Low | 22.90 on 07/10/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 30.30 on 11/12/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,515,922 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 161,803 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 1,663,410,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | 355,760,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 378,140,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | 92,380,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.47 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.73 on 10/24/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/24/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 14.93 | 14.57 | 49.77 | 0.00 | 19.81 |